Bullous Keratopathy
18
3
3
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (18)
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
The Belgian Endothelial Surgical Transplant of the Cornea
Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty
Study of Safety and Tolerability of EO2002 in the Treatment of Corneal Edema
Air Optix® Night and Day® Aqua Therapeutic Wear
AONDA Therapeutic Indication Study I
The ADVISE Study: Advanced Visualization In Corneal Surgery Evaluation
Trial of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
Air Versus SF6 for Descemet's Membrane Endothelial Keratoplasty (DMEK)
Study of Endothelial Keratoplasty Outcomes
Long Term Results of Amniotic Membrane Transplant in Bullous Keratopathy Patients
The SNEC DSAEK EndoGlide Clinical Trial
Corneal Transplantation Guided by OCT RESCAN
Comparison of Two Steroid Regimens to Prevent Transplant Rejection After Corneal Transplant (DMEK)
Outcome After Descemet Membrane Endothelial Keratoplasty (DMEK) and Ultra-thin Descemet Stripping Automated Endothelial Keratoplasty (DSAEK)
Amniotic Membrane Graft In Syntomathic Bullous Keratopathy
The Effects of Riboflavin/ Ultraviolet-A Corneal Cross-linking on the Signs and Symptoms of Bullous Keratopathy
Amniotic Membrane and Anterior Stromal Puncture to the Treatment of Symptomatic Bullous Keratopathy